Realized Gain (Loss) on Disposal of Equity Method Investment
Bristol-Myers Squibb Realized Gain (Loss) on Disposal of Equity Method Investment decreased by 29.5% to $134.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 271.8%, from -$78.00M to $134.00M. Over 3 years (FY 2021 to FY 2025), Realized Gain (Loss) on Disposal of Equity Method Investment shows a downward trend with a -27.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Gains indicate successful exit strategies from strategic partnerships or joint ventures.
Detailed definition
This reflects the realized financial gain or loss from the sale of investments accounted for under the equity method. It...
Peer comparison
Specific to companies with active venture arms or strategic partnership portfolios.
mu_realized_gain_loss_on_equity_method_disposalHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $186.25M | $186.25M | $186.25M | -$200.25M | -$200.25M | -$200.25M | -$200.25M | -$40.00M | -$40.00M | -$40.00M | -$40.00M | $102.00M | $107.00M | $12.00M | -$78.00M | -$22.00M | $190.00M | $190.00M | $134.00M |
| QoQ Change | — | +0.0% | +0.0% | -207.5% | +0.0% | +0.0% | +0.0% | +80.0% | +0.0% | +0.0% | +0.0% | +355.0% | +4.9% | -88.8% | -750.0% | +71.8% | +963.6% | +0.0% | -29.5% |
| YoY Change | — | — | — | — | -207.5% | -207.5% | -207.5% | +80.0% | +80.0% | +80.0% | +80.0% | +355.0% | +367.5% | +130.0% | -176.5% | -120.6% | >999% | — | +271.8% |
Realized Gain (Loss) on Disposal of Equity Method Investment at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's realized gain (loss) on disposal of equity method investment?
- Bristol-Myers Squibb (BMY) reported realized gain (loss) on disposal of equity method investment of $134.00M in Q1 2026.
- How has Bristol-Myers Squibb's realized gain (loss) on disposal of equity method investment changed year-over-year?
- Bristol-Myers Squibb's realized gain (loss) on disposal of equity method investment increased by 271.8% year-over-year, from -$78.00M to $134.00M.
- What is the long-term trend for Bristol-Myers Squibb's realized gain (loss) on disposal of equity method investment?
- Over 3 years (2021 to 2025), Bristol-Myers Squibb's realized gain (loss) on disposal of equity method investment has grown at a -27.8% compound annual growth rate (CAGR), from $745.00M to $280.00M.
- What does realized gain (loss) on disposal of equity method investment mean?
- Profit or loss from selling stakes in companies where the firm has significant influence.